Announcement no. 49/2018
7 August 2018 

Transactions in relation to share buyback program

On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018.

The purpose of the share buyback program is to reduce the Company's share capital and adjust the capital structure by distributing capital to shareholders in line with the Company's Capital Structure and Dividend Policy. The program will end no later than 28 February 2019. The Company may purchase up to 5,000,000 shares under the program, corresponding to 1.1% of the current share capital. The total consideration for shares purchased under the program shall not exceed USD 10 million.

The following transactions have been made under the program in week 22, the period 30 July 2018 - 3 August 2018:

Transactions
Date   No. of shares   Avg. purchase
price in DKK
  Transaction
value in DKK
30 July 2018   18,730   29.99   561,698
31 July 2018   19,230   30.13   579,365
1 August 2018   8,860   29.76   258,322
2 August 2018   1,775   30.10   53,428
3 August 2018   10,000   29.20   292,000
Total    58,415   29.87   1,744,813

Össur has acquired 1,036,910 shares under the program at the average price of DKK 27.93. Following the above transactions Össur's holding of own shares is 5,621,054 corresponding to 1.30% of the Company's total share capital.

The share buyback program on Nasdaq Copenhagen is carried out in accordance with Regulation No. 596/2014 of the European Parliament and of the Council on market abuse ("MAR"), and the Commission delegated regulation No. 2016/1052.

Further information

David Hreidarsson, Investor Relations, dohreidarsson@ossur.com, +354 515 1380

Össur press releases by e-mail

If you wish to receive Össur press releases by e-mail please register at http://www.ossur.com/investors

About Össur

Össur (NASDAQ: OSSR) is a global leader in non-invasive orthopaedics that helps people live a life without limitations.  Its business is focused on improving people's mobility through the delivery of innovative technologies within the fields of braces, supports, prosthetic limbs and compression therapy.  A recognized "Technology Pioneer", Össur invests significantly in research and product development; its award-winning designs ensuring a consistently strong position in the market. Successful patient and clinical outcomes are further empowered via Össur's educational programs and business solutions.  Headquartered in Iceland, Össur has major operations in the Americas, EMEA and APAC, with additional distributors worldwide. www.ossur.com.